Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR. (Q42500361)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR. |
scientific article |
Statements
1 reference
Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR. (English)
1 reference
David G Hicks
1 reference
Sarah M Short
1 reference
Nichole L Prescott
1 reference
Shannon M Tarr
1 reference
Kara A Coleman
1 reference
Brian J Yoder
1 reference
Joseph P Crowe
1 reference
Toni K Choueiri
1 reference
Andrea E Dawson
1 reference
G Thomas Budd
1 reference
Raymond R Tubbs
1 reference
Graham Casey
1 reference
Robert J Weil
1 reference
1 September 2006
1 reference
1 reference
Identifiers
1 reference